Epsilon Healthcare Limited Stock Performance
| HDRPF Stock | USD 0 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and Epsilon Healthcare are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Epsilon Healthcare Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Epsilon Healthcare is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 7 M | |
| Total Cashflows From Investing Activities | -737.6 K |
Epsilon |
Epsilon Healthcare Relative Risk vs. Return Landscape
If you would invest 0.14 in Epsilon Healthcare Limited on September 1, 2024 and sell it today you would earn a total of 0.00 from holding Epsilon Healthcare Limited or generate 0.0% return on investment over 90 days. Epsilon Healthcare Limited is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Epsilon, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Epsilon Healthcare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Epsilon Healthcare's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Epsilon Healthcare Limited, and traders can use it to determine the average amount a Epsilon Healthcare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| HDRPF |
Based on monthly moving average Epsilon Healthcare is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Epsilon Healthcare by adding Epsilon Healthcare to a well-diversified portfolio.
Epsilon Healthcare Fundamentals Growth
Epsilon Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Epsilon Healthcare, and Epsilon Healthcare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Epsilon Pink Sheet performance.
| Return On Equity | -0.81 | |||
| Return On Asset | -0.14 | |||
| Profit Margin | (2.41) % | |||
| Operating Margin | (1.12) % | |||
| Current Valuation | 6.57 M | |||
| Shares Outstanding | 300.35 M | |||
| Price To Book | 0.90 X | |||
| Price To Sales | 1.10 X | |||
| Revenue | 5.5 M | |||
| EBITDA | (8.01 M) | |||
| Cash And Equivalents | 2.34 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 4.44 M | |||
| Debt To Equity | 0.23 % | |||
| Book Value Per Share | 0.04 X | |||
| Cash Flow From Operations | (5.43 M) | |||
| Earnings Per Share | (0.03) X | |||
| Total Asset | 30.37 M | |||
About Epsilon Healthcare Performance
By analyzing Epsilon Healthcare's fundamental ratios, stakeholders can gain valuable insights into Epsilon Healthcare's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Epsilon Healthcare has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Epsilon Healthcare has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada. Epsilon Healthcare Limited was incorporated in 2016 and is based in Sydney, Australia. Epsilon Healthcare operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.Things to note about Epsilon Healthcare performance evaluation
Checking the ongoing alerts about Epsilon Healthcare for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Epsilon Healthcare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Epsilon Healthcare generated a negative expected return over the last 90 days | |
| Epsilon Healthcare has some characteristics of a very speculative penny stock | |
| Epsilon Healthcare has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 5.5 M. Net Loss for the year was (9.24 M) with profit before overhead, payroll, taxes, and interest of 1.92 M. | |
| Epsilon Healthcare Limited has accumulated about 2.34 M in cash with (5.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 28.0% of the company shares are held by company insiders |
- Analyzing Epsilon Healthcare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Epsilon Healthcare's stock is overvalued or undervalued compared to its peers.
- Examining Epsilon Healthcare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Epsilon Healthcare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Epsilon Healthcare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Epsilon Healthcare's pink sheet. These opinions can provide insight into Epsilon Healthcare's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Epsilon Pink Sheet analysis
When running Epsilon Healthcare's price analysis, check to measure Epsilon Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Epsilon Healthcare is operating at the current time. Most of Epsilon Healthcare's value examination focuses on studying past and present price action to predict the probability of Epsilon Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Epsilon Healthcare's price. Additionally, you may evaluate how the addition of Epsilon Healthcare to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |